ANALISIS KEBERHASILAN TERAPI DAN KEAMANAN PENGGUNAAN FIBRINOLITIK PADA PASIEN STEMI (ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION) AKUT (Penelitian Dilaksanakan di RSUD Tarakan Kalimantan Utara)
| Main Author: | IRMA NOVRIANTI, 051715153012 |
|---|---|
| Format: | Thesis NonPeerReviewed Book |
| Bahasa: | ind |
| Terbitan: |
, 2019
|
| Subjects: | |
| Online Access: |
http://repository.unair.ac.id/92246/1/TFK.%2030-19%20Nov%20a%20ABSTRAK.pdf http://repository.unair.ac.id/92246/2/TFK.%2030-19%20Nov%20a%20DAFTAR%20ISI.pdf http://repository.unair.ac.id/92246/3/TFK.%2030-19%20Nov%20a%20DAFTAR%20PUSTAKA.pdf http://repository.unair.ac.id/92246/7/TFK.%2030-19%20Nov%20a%20BR.pdf http://repository.unair.ac.id/92246/ http://lib.unair.ac.id |
Daftar Isi:
- BACKGROUND : Acute coronary syndrome (ACS) is a condition that occurs when there is a blockage of blood flow to the heart. STEMI (ST Elevation Myocardial Infarct) is one form of ACS. Fibrinolytic therapy is recommended by ACC/AHA and PERKI in STEMI when Percutaneous Coronary Intervention (PCI) cannot be performed. OBJECTIVES: This study aims to analyze the effectiveness or successfull of fibrinolytic therapy in patients with STEMI in RSUD Tarakan North Kalimantan in terms of chest pain reduction, ST segment resolution ≥50%, and the presence of reperfusion arrhythmias. This study also identified the safety of fibrinolytic therapy in terms of bleeding occurrences, hypotension and allergic reaction. METHODS: This was an observational retrospective study with a total sampling method, which was conducted at Tarakan District Hospital in North Kalimantan Province in September to October 2019. A review of medical record of the patients was conducted for the period of Januari 2016 sampai Desember 2018. RESULT: Samples that met the inclusion criteria were 55 patients. There were 2 fibrinolytic use namely alteplase and streptokinase. Alteplase was given to 13 patients while streptokinase was given to 42 patients. Almost all patients experienced a decrease in pain scale (49 patients or 89.1%), 42 patients (76.4%) experienced ST segment resolution, and 23 patients (41.8%) experienced reperfusion arrhythmias. Based on these 3 parameters it was found that on average 80% of patients experienced successful reperfusion. None of the patients had major bleeding. The fibrinolytic therapy is safe while in use with only 8 patients had minor bleeding, 14 had hypotension and 3 patients had allergies. CONCLUSION : The success of fibrinolytic therapy in Tarakan District Hospital in North Kalimantan Province is 80%. Safety is not a concern since only minor adverse events was found.